BvA-TeC

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
Keywords	Biotechnology, Teaching, Specialist Training, Specialist Consultancies, Medical R&D
Founded	1988
Employees	1-10

Key Contact at BvA-TeC

Prof U Chris E V. Arnim

CEO

About BvA-TeC

Amongst other things we have developed the only patented, proven & trialled cure for T-1Diabetes. Prof Ulrich von Arnim, MD is an Entrepreneur in the truest sense of the word. HE pursues opportunities without regard to resources currently controlled. HE has tirelessly worked during the last 28 years to find a cure for Type-1 Diabetes. Finally, despite all the hostility of the industry, he managed to establish that Type-1 Diabetes is curable in 8 out of 10 cases and that the patients insulin production, proven by healthy C-peptide levels in their blood, can be fully restored. Jesus, overhearing, shot back, "Who needs a doctor: the healthy or the sick? I'm here inviting the sick, not the spiritually fit." Mark 2:17

BvA-TeC revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

BvA-TeC has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

BvA-TeC has never raised funding before.

Frequently asked questions

BvA-TeC is located in XX.

BvA-TeC was founded in 1988, making it 38 years old. The company has established itself as a significant player in its industry over this time.

BvA-TeC has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at BvA-TeC

Prof U Chris E V. Arnim

CEO

4.8

40,000 users